Aclarion, Inc. (ACON) investor relations documents from the company's IR site: 1 presentation, 1 press release; latest deck 2026-07-29. Read in-app with summaries. First-party data.
Aclarion Corporate Overview: Aclarion (NASDAQ: ACON) provides the Nociscan platform, an AI-powered diagnostic tool for chronic low back pain, targeting a $134B U.S. market.
| Published | Type | Document |
|---|---|---|
| 2026-07-29 | Presentation | Aclarion Corporate Overview |
| Quarterly report | Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption | |
| 2024-11-14 | Press release | Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st |
ACON overview · ACON earnings · ACON financials · ACON KPIs · ACON documents · ACON ownership · ACON peers
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.